Your cart is empty

Janoshik
Batch TB-CA-26A-01
Thymosin Beta-4 Fragment Research Peptide
TB-500 is a synthetic peptide studied in laboratory settings for its role in cellular migration and tissue remodeling pathways. Research commonly explores its influence on cytoskeletal organization, regenerative signaling processes, and overall structural repair mechanisms in controlled experimental models.
This product is intended strictly for laboratory research use within Canada. It is not approved by Health Canada for the diagnosis, treatment, cure, or prevention of any disease. Not for human or veterinary use.
By purchasing, you confirm the material will be used solely for lawful research purposes in accordance with applicable Canadian regulations.
TB-500 is a synthetic research peptide modeled after thymosin beta-4, a naturally occurring peptide involved in cellular signaling processes. It is developed for controlled laboratory investigation within regulated experimental environments.
In scientific literature, TB-500 is studied in experimental models examining cellular migration pathways, cytoskeletal organization, and structural signaling frameworks under in vitro and preclinical research conditions.
Third-party tested for purity, identity, quantity.
TB-500 is a synthetic analogue related to thymosin beta-4, a peptide involved in actin-binding and cellular structural regulation. Research has examined its interaction with cytoskeletal signaling pathways and cellular migration systems within controlled laboratory environments.
Experimental studies evaluate peptide behavior in structural pathway models and tissue-related signaling frameworks under in vitro and preclinical research conditions.
Thymosin beta-4 was initially identified during investigations into thymic peptides and immune-related signaling systems. Subsequent research expanded into studies of actin-binding activity and cellular structural regulation.
TB-500 emerged as a synthetic research analogue used in experimental models evaluating structural pathway interaction and cellular communication systems.
Laboratory investigations into TB-500 have focused on cytoskeletal interaction models and cellular migration pathways. Research frameworks evaluate actin-binding dynamics, structural signaling mechanisms, and peptide-mediated cellular response systems under controlled in vitro and preclinical conditions.
No. Eppix Labs products are supplied exclusively for laboratory research. We do not provide dosing, administration, or usage guidance.
Each vial contains 10mg of lyophilized TB-500. Independent third-party testing verifies purity, identity, and net content per batch.
The vial contains only the peptide preparation. Any laboratory materials required for experimental procedures must be sourced separately.
Duration depends entirely on research protocol, storage conditions, and laboratory application.
Thymosin beta4 accelerates wound healing. J Invest Dermatol 113(3):364–368.
PubMedThymosin beta4 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repair. Nature 432(7016):466–472.
PubMedThymosin beta 4 induces adult epicardial progenitor mobilization and neovascularization.
PubMedRelated

Studied in metabolic research for its effects on glucose regulation, appetite signaling, and energy balance.
From$180.00

Dual incretin receptor agonist studied for glucose regulation, metabolic signaling, and weight pathway research
From$10.00

Immune-modulating peptide studied for T-cell signaling and immune system regulatory pathway research
From$70.00

GHRH analog studied for growth hormone regulation and metabolic pathway signaling research
From$95.00